Trail and immunity: More than a license to kill tumor cells

Cell Death and Differentiation

Volumn 11, Issue , 2004, Pages

  Corazza, N ^a   Brumatti, G ^a   Schaer, C ^a   Cima, I ^a   Wasem, C ^a   Brunner, T ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; NEUTRALIZING ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; AUTOIMMUNE DISEASE; CELL TRANSFORMATION; CYTOTOXICITY; DIABETES MELLITUS; GENE THERAPY; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; MOUSE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; THYMOCYTE; TISSUE INJURY; TUMOR CELL;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12744271893     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401542     Document Type: Article

References (38)

1. Locksley RM et al. (2001) Cell 104: 487-501
2. Ursini-Siegel J et al. (2002) J. Immunol. 169: 5505-5513
3. Kayagaki N et al. (2002) Cell Immunol. 219: 82-91
4. Leverkus M et al. (2000) Blood 96: 2628-2631
5. Hayakawa Y et al. (2004) J. Immunol. 172: 123-129
6. Simon HU (2003) Immunol. Rev. 193: 101-110
7. Renshaw SA et al. (2003) J. Immunol. 170: 1027-1033
8. Ludwig AT et al. (2004) Cancer Res. 64: 3386-3390
9. Simon AK et al. (2001) Proc. Natl. Acad. Sci. USA 98: 5158-5163
10. Wiley SR et al. (1995) Immunity 3: 673-682
11. Newton K et al. (2000) EMBO J. 19: 931-941
12. Lamhamedi-Cherradi SE et al. (2003) Nat. Immunol. 4: 255-260
13. Brunner T et al. (1995) Nature 373: 441-444
14. Cretney E et al. (2003) J. Exp. Med. 198: 491-496
15. Walsh CM et al. (1998) Immunity 8: 439-449
16. Corazza N et al. (2004) Cell Death Differ. in press
17. Strasser A et al. (1995) EMBO J. 14: 6136-6147
18. Bouillet P et al. (2002) Nature 415: 922-926
19. Lin Y et al. (2000) Mol. Cell. Biol. 20: 6638-6645
20. Harris CA et al. (2001) J. Biol. Chem. 276: 37754-37760
21. Putcha GV et al. (2003) Neuron 38: 899-914
22. Brunner T et al. (2003) Semin. Immunol. 15: 167-176
23. Griffith TS et al. (1995) Science 270: 1189-1192
24. Lee HO et al. (2002) J. Immunol. 169: 4739-4744
25. Strebel A et al. (2002) Int. J. Cancer 100: 627-634
26. Phillips TA et al. (1999) J. Immunol. 162: 6053-6059
27. Nagata S et al. (1995) Immunol. Today 16: 39-43
28. Cretney E et al. (2002) J. Immunol. 168: 1356-1361
29. Sedger LM et al. (2002) Eur. J. Immunol. 32: 2246-2254
30. Liu Z et al. (2003) J. Clin. Invest. 112: 1332-1341
31. Mi QS et al. (2003) Diabetes 52: 1967-1975
32. Lamhamedi-Cherradi SE et al. (2003) Diabetes 52: 2274-2278
33. Suter T et al. (2003) Eur. J. Immunol. 33: 2998-3006
34. Lunemann JD et al. (2002) J. Immunol. 168: 4881-4888
35. Janssen O et al. (2003) Cell Death Differ. 10: 1215-1225
36. Watts AD et al. (1999) EMBO J. 18: 2119-2126
37. Chou AH et al. (2001) J. Immunol. 167: 1347-1352
38. Chen NJ et al. (2001) J. Immunol. 166: 270-276